Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)

Zhenwei Peng, Wenzhe Fan, Bowen Zhu, Guoying Wang, Junhui Sun, Chengjiang Xiao, Fuxi Huang, Rong Tang, Yu Cheng, Zhen Huang, Yuchuang Liang, Huishuang Fan, Liangliang Qiao, Fuliang Li, Wenquan Zhuang, Baogang Peng, Jiping Wang, Jiaping Li, Ming Kuang

Journal of Clinical Oncology, 2022

Sun Yat-sen University, The First Affiliated Hospital, Sun Yat-sen University, Sun Yat-sen University Cancer Center, Third Affiliated Hospital of Sun Yat-sen University, First Affiliated Hospital Zhejiang University, Guangdong Provincial People's Hospital, Panyu District Central Hospital, Hainan General Hospital, Huizhou Central People's Hospital, Jiangmen Central Hospital, Dongguan People’s Hospital, Guangzhou University of Chinese Medicine, Gaozhou People's Hospital, Brigham and Women's Hospital, Harvard University

Publisher Website

Abstract

This research paper explore the methodology and findings associated with Journal of Clinical Oncology. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

418

Citations

View on Google Scholar

Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)

Abstract

Journal Details

Join JournalsHub

Welcome Back